All articles tagged with #breast cancer screening
A Tel Aviv University study presented at ESC Congress 2026 finds AI can predict cardiovascular disease risk from routine mammograms, with AUROCs of 0.79 for hypertension, 0.78 for ischaemic heart disease, and 0.86 for stroke, using data from 29,921 women and 97,364 mammograms; the research suggests mammography could screen for heart health alongside breast cancer, though further validation is needed before clinical use.
Guidelines for routine breast screening differ: ACP recommends average‑risk women start at 50–74 with biennial mammograms, USPSTF suggests starting at 40 with the same 2‑year interval, and ACS has long urged yearly screening starting at 45 (with 40 optional) and then switching to every year or every other year for older women. The disagreement reflects challenges in predicting risk and balancing benefits with harms, especially since dense breasts and tumor biology vary. New research (like the WISDOM trial) and tools to assess individual risk could tailor schedules in the future, including the potential use of DBT and broader gene testing. For now, consult a doctor about personal risk and stick with a chosen screening plan.
Saskatchewan unveiled its second mobile mammography unit to expand access to breast cancer screening in rural and northern communities. Together with the first unit, the two trailers will visit about 42 communities annually and screen roughly 6,000–7,500 people per unit each year, with 10-minute appointments, aiming to reach about 15,000 women. The project is funded by $5.2 million from the Cancer Foundation of Saskatchewan and more than $475,000 annually for operations, with the screening eligibility expanded to women 43 and older as of Jan. 2, 2026 (screenings recommended every two years for healthy women).
KOMO News anchor Kelly Koopmans shares her experience getting her first screening mammogram at Seattle’s Swedish Breast Imaging Center after turning 40, highlighting that about 1 in 8 women will develop breast cancer and that mammograms can detect cancer up to two years before symptoms. The 10-minute exam involves four images and may require follow-up; most recalls are not cancer. Her results were negative, and doctors emphasize annual screening for average-risk individuals to catch issues early, underscoring the importance of being proactive about health.
For women with dense breast tissue, 3-D mammography is the preferred screening method as it is more effective at detecting cancer than traditional mammograms. Additional screening options like ultrasounds may be considered for those at intermediate risk, while MRIs are reserved for high-risk individuals. Risk assessment tools can help determine the most appropriate screening strategy, and women should discuss their personal risk factors with their healthcare providers.
Hospital staff are encouraging trans and non-binary individuals to attend mammogram appointments for breast cancer screening, emphasizing that early detection saves lives and that everyone's health matters, regardless of gender identity.
Mammograms are less effective for women with dense breast tissue, making it harder to detect cancer. There is no clear protocol on how to handle this issue, and medical experts disagree on the need for additional screening tests. While some believe that supplemental screenings are necessary, others argue that the current evidence does not support increased follow-up screenings for all women with dense breasts. Insurance coverage for these additional tests remains a significant hurdle, but efforts are being made to expand coverage and close loopholes in individual state laws.
Artificial intelligence (AI) is revolutionizing breast cancer screenings by assisting physicians in detecting more cancers and predicting outcomes. Preliminary results from a study show that AI-assisted mammography screening detected 20% more cancers, while research from Northwestern Medicine suggests that AI could help spare breast cancer patients unnecessary chemotherapy treatments. AI is used to analyze mammograms and breast sonograms, sorting them into different risk levels. However, doctors emphasize that AI is not meant to replace human doctors but rather provide an additional tool in the screening process.
Breast imaging experts have criticized a recent study published in JAMA Internal Medicine, calling it "invalid" and "specious." The study evaluated the impact of various cancer screening tests on life-days gained and reported that mammography led to zero days gained, while CT lung cancer screening led to 107 days gained on average. Experts pointed out flaws in the study's design, including the failure to assess the impact of screening participation and the use of all-cause mortality as an inappropriate study approach. They emphasized the importance of developing better ways to detect breast cancer and reducing breast cancer-related deaths through screening programs.
A new study suggests that breast cancer screenings for women over the age of 70 may be unnecessary and even harmful for some individuals due to the risks of overdiagnosis. The research highlights the importance of individualized plans with doctors, as there is no one-size-fits-all solution for older women. Different medical organizations provide conflicting guidelines on when to stop screenings, and the lack of research on older women further complicates the issue. Factors such as other medical conditions, risk for breast cancer, insurance coverage, and physical capability should be considered when making screening decisions. Ultimately, doctors can help patients navigate these decisions and communicate the best course of action.
The world's largest trial of its kind has found that the use of artificial intelligence (AI) in breast cancer screening is safe and can significantly reduce the workload of radiologists. The study compared AI-supported screening with standard care and found that AI screening was as effective as two radiologists working together, did not increase false positives, and reduced the workload of radiologists by almost half. The interim analysis concluded that AI-supported mammography screening is safe and could help address the shortage of radiologists. However, further research is needed to assess the impact on patient outcomes and cost-effectiveness. The final trial results are expected in the coming years.
The US Preventive Services Task Force (USPSTF) is finalizing an update to its recommendations on breast cancer screening, proposing to lower the initial age for routine mammogram screening from 50 to 40. However, concerns have been raised about the costs associated with potential follow-up tests and the lack of coverage for these tests. The update has also reignited debates about the timing and frequency of screening, as well as the need for a more nuanced approach based on racial and ethnic groups. Additionally, there is ongoing uncertainty regarding the benefits and harms of additional screening for women with dense breasts. Efforts are underway in Congress to end copays for breast screening, and the final guidelines will be used to guide discussions between primary care physicians and patients.
Researchers from the University of Maryland School of Medicine tested ChatGPT, an AI chatbot from OpenAI, on 25 questions related to breast cancer screening guidelines and found that it answered accurately 88% of the time. However, the chatbot gave outdated information in one response and inconsistent responses in two others. Experts caution that ChatGPT's responses should be vetted by a doctor and that it is not yet ready for the real world.